CAPS Rating

Eagleeyedjoe (58.84)

Results 1 - 20 of 40 : 1 2 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
26/03/2012 NVDA.US 4 out of 5 Outperform 5Y $14.50 $14.40 (-0.62%) -0.71% +17.40% -18.11
26/03/2012 BOH.US 4 out of 5 Outperform 5Y $45.75 $49.41 (+0.61%) +8.01% +17.40% -9.39
26/03/2012 KKD.US 2 out of 5 Outperform 5Y $7.42 $17.86 (+5.00%) +140.70% +17.40% +123.30
26/03/2012 SI.US 5 out of 5 Outperform 5Y $100.23 $107.29 (+0.73%) +7.04% +17.40% -10.36
26/03/2012 ATVI.US 4 out of 5 Outperform 5Y $12.55 $14.59 (-0.95%) +16.22% +17.40% -1.18
26/03/2012 PPL.US 4 out of 5 Outperform 5Y $25.97 $29.46 (+1.13%) +13.46% +17.40% -3.95
26/03/2012 GLW.US 5 out of 5 Outperform 5Y $13.95 $15.19 (+0.53%) +8.90% +17.40% -8.50
25/11/2011 RTN.US 4 out of 5 Outperform 5Y $40.26 $68.07 (+0.43%) +69.06% +42.41% +26.66
25/11/2011 CAG.US 4 out of 5 Outperform 5Y $22.65 $34.50 (-0.26%) +52.29% +42.41% +9.88
22/06/2011 AZN.US 4 out of 5 Outperform 5Y $43.09 $50.98 (+0.02%) +18.32% +28.43% -10.11
22/06/2011 SCCO.US 4 out of 5 Outperform 5Y $26.44 $29.76 (-0.30%) +12.56% +28.43% -15.87
22/02/2011 CRTX.US 3 out of 5 Outperform 5Y $5.46 $8.45 (-1.86%) +54.76% +24.50% +30.26
22/02/2011 PAYX.US 4 out of 5 Outperform 5Y $30.47 $37.80 (-0.11%) +24.04% +24.50% -0.46
22/02/2011 NTES.US 4 out of 5 Outperform 5Y $43.04 $62.43 (+0.56%) +45.06% +24.50% +20.56
22/02/2011 K.US 3 out of 5 Outperform 5Y $48.87 $64.92 (+0.37%) +32.84% +24.50% +8.34
22/02/2011 LEG.US 4 out of 5 Outperform 5Y $20.89 $32.78 (+0.74%) +56.95% +24.50% +32.45
18/02/2011 CASS.US 4 out of 5 Outperform 5Y $36.70 $47.04 (+2.69%) +28.19% +23.42% +4.76
18/02/2011 KO.US 5 out of 5 Outperform 5Y $29.99 $40.93 (+0.61%) +36.49% +23.39% +13.10
18/02/2011 CGNX.US 5 out of 5 Outperform 5Y $28.25 $45.99 (+1.57%) +62.82% +23.39% +39.43
18/02/2011 HSTM.US 3 out of 5 Outperform 5Y $7.80 $26.60 (+0.11%) +241.03% +23.39% +217.64
Results 1 - 20 of 40 : : 1 2 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.